NCT02337634View on ClinicalTrials.gov

Milk Thistle in Pathological Gambling

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Pathological GamblingGambling Disorder
Interventions
DRUG

Placebo

Taken as two 150mg capsules BID for 2 weeks, then 300mg BID for remainder of the study.

DRUG

Milk Thistle

Taken as two 150mg capsules BID for 2 weeks, then 300mg BID for remainder of the study.

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT02337634 - Milk Thistle in Pathological Gambling | Biotech Hunter | Biotech Hunter